Chemical industry – Page 38
-
ResearchPatent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways
-
BusinessAntifouling coatings cling to copper
Copper coatings keep ships clear from unwanted sea life but environmental concerns mean some are keen to move away from the metal. Can it be replaced?
-
OpinionWhat are the rate-limiting steps in drug discovery?
Getting more drugs to market is not just a chemistry problem
-
BusinessPfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
BusinessChinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
CareersRethinking industrial placements
How SMEs are bridging the gap between undergraduates and industry
-
ArticleStrength through diversity
Why people should be at the heart of a forward-thinking contract research organisation
-
BusinessHow many papers do you read a week?
Everyone needs a strategy to keep up with the literature
-
BusinessGSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
-
OpinionHow science shapes our psychology
We learn to embrace the unexpected, follow evidence over opinion and accept that most experiments fail
-
BusinessChemicals industry roundup 2018
Industry growth remains strong despite tariff disputes, political uncertainty and supply chain challenges
-
BusinessPharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
BusinessBayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce
-
BusinessSartan drug contamination brings cancer uncertainty
Levels of nitrosamines and other carcinogens in affected tablets of valsartan and related drugs similar to smoking 20 cigarettes a day
-
BusinessSensing the sweet spot
Ziylo’s selective glucose-binding molecule could open doors to smart insulin for diabetes
-
BusinessArrests in China follow massive leak into the Taiwan Strait
Seven charged with criminal negligence after release of 70 tonnes of aromatic hydrocarbons sickened over 50 people
-
OpinionPushing the limits of patent protection
Some methods of extending exclusivity rights raise legal and ethical questions
-
BusinessBreaking the silence of RNA interference drugs
A wave of treatments is set to follow the first approval of an RNAi therapy